Home
/ Spirox
/ Competitors

Spirox Competitors and Similar CompaniesClear all

Spirox's competitors and similar companies include NuVasive, Amplitude Surgical and Ortoma.

	Spirox Spirox (formerly known as Nasoform) is a medical device company focused on developing minimally invasive technologies to improve the quality of life for patients with nasal obstruction.	NuVasive NuVasive is a company that provides surgery transformation and clinical support solutions for the healthcare industry.	Amplitude Surgical Amplitude Surgical SA is a France-based company engaged in the field of orthopedic surgeries.	Ortoma Ortoma is a company that engages in the development of products and solutions for orthopedic and joint implant surgery.
Founding Date	Founding Date 2012	Founding Date 1997	Founding Date N/A	Founding Date 2001
Type	Type Subsidiary	Type Subsidiary	Type Public	Type Private
Tags	Tags Healthcare healthtech medical devices surgical solutions	Tags Healthcare healthtech medical devices surgical solutions	Tags Healthcare healthtech medical devices surgical solutions	Tags Healthcare healthtech medical devices surgical solutions
Locations	Locations Menlo Park, US HQ	Locations San Diego, US HQ Melbourne, AU Barueri, BR Bogotá, CO Bremen, DE Milan, IT Tokyo, JP see more	Locations Valence, FR HQ North Sydney, AU Stepney, AU Nivelles, BE Nieder Olm, DE Bunkyo City, JP see more	Locations Göteborg, SE HQ
Employees	Employees 2517% decrease	Employees 3,0003% increase	Employees 434	Employees N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $1.2b (FY, 2022)	Revenue (est.) €106m (FY, 2024)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $336.5m (FY, 2022)	Cost of goods €21.3m (FY, 2024)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $865.4m (FY, 2022)	Gross profit €85.8m (FY, 2024)	Gross profit N/A
Net income	Net income N/A	Net income $40.4m (FY, 2022)	Net income €1.5m (FY, 2024)	Net income (kr9.7m) (FY, 2019)
Funding
Total funding raised	Total funding raised $ 69.5m	Total funding raised $ 65.3m	Total funding raised N/A	Total funding raised N/A